Goldman Sachs’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Sell
73,923
-18,778
-20% -$70.2K ﹤0.01% 5943
2025
Q4
$324K Buy
92,701
+74,706
+415% +$261K ﹤0.01% 5829
2025
Q3
$38.5K Buy
+17,995
New +$38.1K ﹤0.01% 6196
2023
Q2
Sell
-18,127
Closed -$52.2K 5731
2023
Q1
$52.2K Buy
+18,127
New +$52.9K ﹤0.01% 5545
2022
Q3
Sell
-22,241
Closed -$130K 6242
2022
Q2
$130K Buy
22,241
+5,580
+33% +$28.6K ﹤0.01% 5781
2022
Q1
$109K Sell
16,661
-94,058
-85% -$926K ﹤0.01% 6080
2021
Q4
$1.42M Sell
110,719
-52,489
-32% -$734K ﹤0.01% 4541
2021
Q3
$2.26M Sell
163,208
-23,631
-13% -$249K ﹤0.01% 4083
2021
Q2
$1.93M Buy
186,839
+26,002
+16% +$258K ﹤0.01% 4231
2021
Q1
$1.55M Buy
160,837
+4,484
+3% +$44.9K ﹤0.01% 4242
2020
Q4
$1.13M Sell
156,353
-15,804
-9% -$105K ﹤0.01% 4123
2020
Q3
$811K Buy
172,157
+25,370
+17% +$126K ﹤0.01% 4213
2020
Q2
$815K Buy
146,787
+107,448
+273% +$447K ﹤0.01% 4096
2020
Q1
$141K Sell
39,339
-173,100
-81% -$1.16M ﹤0.01% 4845
2019
Q4
$1.8M Buy
212,439
+195,417
+1,148% +$1.41M ﹤0.01% 3721
2019
Q3
$115K Buy
17,022
+4,480
+36% +$31.8K ﹤0.01% 4945
2019
Q2
$84K Sell
12,542
-136,577
-92% -$742K ﹤0.01% 4953
2019
Q1
$941K Buy
+149,119
New +$1.15M ﹤0.01% 4090

Other funds holding APYX